Renal micropuncture and renal 2-photon imaging are seminal techniques in renal physiology. However, micropuncture is limited by dependence on conventional microscopy to surface nephron features, and 2-photon studies are limited in that interventions can only be assessed at the organ, rather than the nephron level. In particular, micropuncture studies of the glomeruli of mice have been challenged by the paucity of surface glomeruli in mice. To address this limitation in order to pursue studies of aspirate from Bowman's space in mouse physiologic models, we developed 2-photon glomerular micropuncture. We present a novel surgical preparation that allows lateral access to the kidney while preserving the required vertical imaging column for 2-photon microscopy. Administration of high molecular weight fluorescein isothiocyanate (FITC)dextran is used to render the renal vasculature and therefore glomeruli visible for 2-photon imaging. A quantum dot-coated pipette is then introduced under stereotactic guidance to a glomerulus selected from the several to many which may be visualized within the imaging window. In this protocol, we provide details of the preparation, materials, and methods necessary to carry out the procedure. This technique facilitates previously-impossible physiologic study of the kidney, including recovery of filtrate from Bowman's space and all segments of the nephron within the imaging depth limit, about 100 µm below the renal capsule. Pressure, charge and flow may all be measured using the introduced pipette. Here, we provide representative data from liquid chromatography/mass spectrometry performed on aspirate from Bowman's space. We expect this technique to have wide applicability in renal physiologic investigation.
Introduction
The purpose of this procedure is to provide routine micropuncture access to Bowman's space and other glomerular structures in mice. Micropuncture studies for renal physiology have been limited to 1-photon microscopy, which can only image within a few microns of the kidney surface, and which offers limited precision in the z-dimension. Because mice have few surface glomeruli, it is not always possible to find a surface glomerulus by 1-photon microscopy, therefore most micropuncture studies have been carried out in Munich-Wistar rats, which have more numerous surface glomeruli. Therefore, the benefits of working in mouse models have been limited in micropuncture studies 1, 2, 3 . Recent advances in imaging technologies, including micro-CT 4, 5 , nanoparticle imaging 6 , and imaging mass spectrometry 7 have greatly enhanced the range of modalities applicable to glomerular physiology, but there remains no substitute for the unique ability to intervene and sample that micropuncture provides. Therefore extending the use of micropuncture using the techniques presented here is expected to facilitate novel renal physiology studies, in particular, evaluation of the content of renal filtrate (i.e., metabolomics) and basic physiology of transgenic mice, such as measurements of filtrate pressure and charge, previously performed only in rats.
In this technique, use of 2-photon microscopy allows visualization and micropipette access to renal structures up to about 100 µm below the renal capsule. Multiple (5-10) glomeruli are therefore accessible to micropuncture in every mouse kidney thus far imaged. Although this technique shares some features with conventional renal micropuncture, it was designed de novo and extensive modifications from conventional technique are required. In this protocol we demonstrate aspiration of fluid from Bowman's space and show example results of subsequent analysis with mass spectrometry (nanoproteomics) 8, 9, 10, 11 . Downstream use of mass spectrometry requires a specialized sample preparation workflow, which is also demonstrated here.
Copyright © 2018 Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License October 2018 | 140 | e58206 | Page 3 of 9 without this precise prepositioning. Because quantum dots fluoresce at the same (in this case, red) wavelength regardless of excitation wavelength, the DAPI excitation produces red fluorescence which is tightly focused on the tip, illustrated in Figure 2 . 6. Change the excitation setting to red fluorescent protein (RFP) and visualize the pipette in the ocular, then precisely center it in the ocular view. 7. Switch to 2-photon and find the pipette under 2-photon, placing it precisely in the center of the image. This is the registration position. 8. Save an image of the pipette. 9. Register the stage and the micropipette controller coordinates. NOTE: Use the supplemental .html file, which will execute calculations using JavaScript code, (advantageous on systems which do not have installed spreadsheet software) or a spreadsheet to calculate the offset between stage and pipette coordinates and to calculate the target coordinates for the pipette controller. 10. Remove the pipette from the water column in the x axis, keeping z and y the same. 11. Move the pipette Z to the target glomerulus Z (i.e., move the pipette down in the Z direction below the coverslip) 12. Move the pipette Y to the target glomerulus Y coordinate. 13. Move the 2-photon live view to the target glomerulus Z and then to the edge of the kidney and note the SX. 14. Calculate the kidney edge PX using the offset from the registration SX. 15. Move the stage toward the pipette (increase the SX) such that the edge of the kidney is far to the left of the screen, but still visible. 16 . Advance the pipette quickly to about 100 µm less than the kidney edge PX calculated above. 17. Locate the pipette tip, advancing the pipette slowly. Increase the red gain and watch the red pixel histogram (the pixel distribution shifts before the pipette is imaged in the window, due to the extreme brightness of quantum dots and off-target fluorescence). 18. Advance to the kidney edge under live 2-photon imaging.
NOTE: Prior to entering the renal capsule, it is possible to redirect the pipette in the Y and Z dimensions. However, this may break the pipette tip. A more conservative measure, if the pipette is off target, is to withdraw in the X dimension up to 2 cm, redirect, and then return in the X dimension to the kidney edge. Once the pipette is within the tissue, movement in any axis other than X leads to pipette flexion which requires great experience to make use of, and frequently leads to breakage. 19. Drive the pipette in the X axis slowly to the glom target PX, keeping an eye on the SX. (It is helpful to occasionally go back to the glomerulus to see if it has shifted at all upon insertion of the micropipette). 20. When you are in the correct location, document position with a z-stack.
NOTE: With the micropipette in place, drugs, proteins, or fluorescent tracers may be injected, fluid may be aspirated for later analysis, or pressure or charge relative to another electrode may be measured.
Aspiration of Fluid from Bowman's Space
1. Set the micropump to inject 100 nL of perfluorodecalin over 2 min to ensure patency of the pipette and reduce confounding from pipette plugging during entry. Reimage to ensure pipette position. 2. Wait 4-6 min for additional filtration. 3. Set the micropump to aspirate up to 300 nL at a rate of up to 50 nL/min. NOTE: Changes in glomerular morphology are not observed with this rate, suggesting it does not alter the rate of delivery of fluid to the space during aspiration. As there is no oil block as in conventional micropuncture, recovery of this volume, necessary for mass spectrometry, could include some of the injected perflourodecalin and possibly tubular fluid. For assays such as ion-sensitive electrode measurements fluorescence spectroscopy, polymerase chain reaction, and other sensitive endpoints, lower volumes may be used. If mass spectrometry is not the endpoint, mineral oil and standard micropuncture techniques can be used to measure the aspirated volume prior to storage. 4. Image once more. 5. Withdraw the pipette and preserve the sample, adding TRIS buffer and storing at -80° prior to analysis. 6. Euthanize the mouse using an overdose of isoflurane or other approved method.
NOTE: Filtrate enters the space by filtration from the glomerular capillaries. The single-nephron glomerular filtration rate (SNGFR) in mice is reported between 8-14 nL/min. 3 Starling forces govern SNGFR, however, and negative hydrostatic pressure in Bowman's space therefore may increase SNGFR. Standard micropuncture methods use tubular blockade with oil and neutral pressure for tubular fluid sampling, however these compounds interfere with mass spectrometry (see below); therefore, in this technique the early proximal tubule remains patent. Further, at the time of aspiration, Bowman's space contains an unknown, but positive volume of filtrate. Therefore, fluid aspiration rate may exceed SNGFR. NOTE: In the experiments described here, the goal was to obtain a larger than usual sample of glomerular filtrate for mass spectrometry analysis by nanoproteomic techniques. Since use of mass spectrometry precludes use of oil blocks with mineral oil or wax (complex mixtures of organic molecules which reduce signal:noise in mass spectrometry) perfluorodecalin is used to fill the micropipette and syringe. Perflourodecalin is not known to block tubular flow, but is biologically inert and does not interfere with mass spectrometry.
Representative Results
This procedure requires a unique surgical preparation of the kidney for 2-photon imaging and access, which is illustrated in Figure 1 . This preparation shown here allows a vertical imaging column with the objective above the kidney with few density changes for best-possible optics for 2-photon microscopy simultaneously with lateral access for the pipette, driven exclusively in the horizontal (x) dimension. Partial extrusion of the kidney prevents excess tension on the renal pedicle and preserves vascular flow, and construction of a custom kidney support enables the two objectives of imaging and access. The second challenge in this procedure is precise positioning of the pipette within the kidney in 3 dimensions, which requires registration of the pipette and stage coordinate systems. The critical step for this process is illustrated in Figure 2 , which shows the pipette being spotted in the water column of the 2-photon microscope under DAPI-excitation. Entering the water column and registering the coordinates of the pipette to those of the stage prior to entering the kidney is critical to enable precise stereotactic positioning of the pipette within the target Bowman's space. The pipette enters the imaging water column from the right. With DAPI excitation turned on, the red quantum dot-coated pipette fluoresces brightly in the red-orange, and it can be carefully positioned under the middle of the objective. As the excitation beam passes through the center of the objective, the pipette may be freely moved to the point of maximum fluorescence, ensuring that it will be visible in the eyepiece.
Proper pipette pulling and glomerulus selection are critical to the success of this protocol, as illustrated in Figure 3, Figure 4, Figure 5 . In Figure  3A , a properly-pulled, red-fluorescent quantum dot-coated glass micropipette imaged in the fluid column during the pipette registration portion of the procedure can be seen. The tip is 6 microns in width. In Figure 3B , a poorly-pulled pipette with 12 µm tip is shown. This pipette cannot penetrate the renal capsule without causing vascular trauma due to the 12 µm diameter and irregular tip surface (note the bur at the top of the bevel). In Figure 3C and 3D, the importance of optimal positioning rather than imaging of the target glomerulus is shown. The beautiful, nearsurface glomerulus illustrated in Figure 3C demonstrates favorable imaging (due to its surface position at 20 µm below the renal capsule) but would not be suitable for access by this procedure because it is too close to the surface, and the pipette would hit the coverslip. In Figure 3D , optimally-positioned glomeruli are shown. Note the different scale used to illustrate both glomeruli (scale bars are all 50 µm). These glomeruli appear less sharp because of refraction caused by depth; this image was taken at 70 µm below the renal capsule. The lateral kidney edge is 250 µm to the right, making both of these glomeruli accessible. During an access procedure, imaging is tightly focused on the target glomerulus as in Figure 4 , and every-second image acquisition is used, allowing the investigator to precisely observe positioning of the pipette in Bowman's space. Figure 4 illustrates a typical renal entry and the result, a pipette tip within Bowman's space. In Figure 4A , a mean intensity projection from a z-stack with orthogonal views demonstrates the pipette tip in Bowman's space. Note that there is red pipette tip spectral artifact (round ball of fluorescence) due to extremely bright fluorescence of the quantum dots arranged on the conical section of the tip. In Figure 4B , a volume projection of z-stack data demonstrates another pipette in Bowman's space. Note that the pipette dragged Bowman's capsule in the direction of travel on entry, creating apparent tenting behind the tip as described in the protocol.
In Figure 5 , the results of a failed procedure are shown in which a pipette with a too-large opening broke at the renal capsule, causing bleeding. The pipette was too blunt; on attempting to pass the renal capsule, the capsule was pushed ahead of the pipette tip until breakage occurred. In this image, the renal capsule is visible, enhanced by subcaspular bleeding, in FITC-fluorescent green. FITC signal is visible within the pipette itself, indicating that blood under pressure entered the pipette lumen. The arrow points to many red blood cells visible within the pipette lumen as filling defects in the FITC-dextran. Figure 6 depicts a representative mass spectrum obtained from Bowman's space aspirate, mouse urinary protein 17 (MUP17). Lastly, Table 1 demonstrates example results of successful aspiration procedures, listing proteins identified using nanoscale mass spectrometry on aspirate collected over 6 minutes from each of 3 mice. In each case, the pipette was imaged as it was withdrawn from Bowman's space, and no FITC fluorescence was observed within Bowman's space or the pipette lumen, indicating lack of aspirate contamination with plasma. 17 proteins, primarily of low molecular weight, were identified from a minimum of 2 unique peptides per protein. Spectral counts are low, consistent with prior estimates of protein in the glomerular filtrate, and known filtered proteins, such as vitamin D binding protein (VTDB), albumin (ALBU), and major urinary protein 17 (MUP17) are present. 
